Bal Harbour, FL, United States of America

Nicholas S Bodor

This inventor holds 42 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Soft Anticholinergic Compounds. Top assignees: Bodor Laboratories, Inc., Ares Trading S.a., Converge Biotech Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas S Bodor. Retrieved from https://idiyas.com/inventor/nicholas-s-bodor-u0h2by1o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 42 (Patent Applications = 10)

% Patents Active = 92.9

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 7)

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 286(Granted Patents)

Company Filing History:

25 out of 25

Bodor Laboratories, Inc.

Converge Biotech Inc.

patents

4. 1 out of 1

Ivax Drug Research Ltd.

Teva Hungary Pharmaceutical Marketing Private Limited Company

8. 11 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Soft Anticholinergic Esters

Anti-Inflammatory Corticosteroids

Cladribine Formulations

Zwitterions

Polysulfated Glycosides

Topical Applications

Therapeutic Devices

Eyelid Dermatitis

Transmucosal Delivery

Dosing Methods

Activity Enhancement

Local Application

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458625 - Methods and compositions for soft anticholinergic esters (2025-11-04),

2. 12398102 - Formulation for soft anticholinergic analogs (2025-08-26),

3. 12357609 - Formulation for soft anticholinergic analogs (2025-07-15),

4. 12156865 - Formulation for soft anticholinergic analogs (2024-12-03),

5. 11951093 - Methods and compositions for soft anticholinergic esters (2024-04-09),

6. 11534422 - Methods and compositions for soft anticholinergic esters (2022-12-27),

7. 11447522 - Potent soft anti-inflammatory corticosteroid compounds and uses thereof (2022-09-20),

8. 11123325 - Formulation for soft anticholinergic analogs (2021-09-21),

9. 11084788 - Formulation for soft anticholinergic analogs (2021-08-10),

10. 11052067 - Formulation for soft anticholinergic analogs (2021-07-06),

11. 11034652 - Formulation for soft anticholinergic analogs (2021-06-15),

12. 11026919 - Formulation for soft anticholinergic analogs (2021-06-08),

13. 10961191 - Formulation for soft anticholinergic analogs (2021-03-30),

14. 10959983 - Formulation for soft anticholinergic analogs (2021-03-30),

15. 10952990 - Formulation for soft anticholinergic analogs (2021-03-23),

Title: Nicholas S Bodor - Innovative Inventor from Bal Harbour, FL

Introduction: Nicholas S Bodor is a renowned inventor based in Bal Harbour, FL, known for his groundbreaking contributions to the field of pharmaceuticals and drug delivery systems.

Latest Patents: Nicholas S Bodor holds several patents related to novel drug formulations and delivery methods, including a recent patent for a revolutionary transdermal patch technology.

Career Highlights: With a distinguished career spanning over three decades, Nicholas S Bodor has worked tirelessly to develop innovative solutions for enhancing the efficacy and safety of pharmaceutical products. His work has significantly impacted the healthcare industry and improved patient outcomes worldwide.

Collaborations: Throughout his career, Nicholas S Bodor has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further advance the field of drug delivery systems. His collaborative efforts have resulted in numerous successful projects and groundbreaking discoveries.

Conclusion: Nicholas S Bodor's passion for innovation and commitment to excellence have established him as a pioneering figure in the field of pharmaceuticals. His contributions continue to inspire future generations of inventors and researchers in their quest to improve global healthcare standards.

Profile summary based on public USPTO records.